Enhancer ID: | E_01_0005 |
Species: | human |
Position : | chr12:102954386-102956386 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Chronic lymphocytic leukemia |
Pubmed ID: | 29344090 |
Enhancer experiment: | qPCR,FISH |
Enhancer experiment description: | As a consequence of the rearrangement ASCL1 was brought into proximity of the IGHJ-C? enhancer and was highly overexpressed in the aberrant B-cells of the patient, as shown by qPCR and immunohistochemistry. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | As a consequence of the rearrangement ASCL1 was brought into proximity of the IGHJ-C? enhancer and was highly overexpressed in the aberrant B-cells of the patient, as shown by qPCR and immunohistochemistry. |
TF name : | ASCL1(AI225900,ASH1,Mash1,bHLHa46) |
TF experiment: | qPCR,FISH |
TF experiment description: | As a consequence of the rearrangement ASCL1 was brought into proximity of the IGHJ-C? enhancer and was highly overexpressed in the aberrant B-cells of the patient, as shown by qPCR and immunohistochemistry. |
Enhancer function : | As a consequence of the rearrangement ASCL1 was brought into proximity of the IGHJ-C? enhancer and was highly overexpressed in the aberrant B-cells of the patient, as shown by qPCR and immunohistochemistry. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
As a consequence of the rearrangement ASCL1 was brought into proximity of the IGHJ-C? enhancer and was highly overexpressed in the aberrant B-cells of the patient, as shown by qPCR and immunohistochemistry. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
ASCL1 | Notch-mediated HES/HEY network | pid | 48 |
ASCL1 | Notch | netpath | 76 |
ASCL1 | Hs_Dopaminergic_Neurogenesis_WP2855_87239 | wikipathways | 19 |
ASCL1 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |